Protalix and Chiesi Report Positive Results From Fabry Disease Trial Post author:PacConAdmin Post published:March 21, 2022 Post category:Drug Industry Daily The rare inherited condition Fabry Disease (FD) may soon have a new treatment. Source: Drug Industry Daily You Might Also Like EMA Publishes 1,000th Post-Marketing Study in Online Registry February 13, 2017 FDA Releases Draft Supply Chain Guidances on Trading Partners and Electronic Reporting July 5, 2022 Democratic Reps. Discuss Medicare Price Negotiation with an ‘Enthusiastic’ President March 8, 2017